Brian E. Glessner

Array ( [id] => 3827379 [patent_doc_number] => 05783596 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Treatment for atherosclerosis and other cardiovascular and inflammatory diseases' [patent_app_type] => 1 [patent_app_number] => 8/477881 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 10608 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 210 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783596.pdf [firstpage_image] =>[orig_patent_app_number] => 477881 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3857534 [patent_doc_number] => 05705533 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => '10-thio-substituted 1,8-dihydroxy-9 (10H) -anthracenone pharmaceuticals' [patent_app_type] => 1 [patent_app_number] => 8/487344 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6339 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705533.pdf [firstpage_image] =>[orig_patent_app_number] => 487344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3893318 [patent_doc_number] => 05750351 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Treatment for atherosclerosis and other cardiovascular and inflammatory diseases' [patent_app_type] => 1 [patent_app_number] => 8/474530 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 37 [patent_no_of_words] => 17327 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750351.pdf [firstpage_image] =>[orig_patent_app_number] => 474530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3860293 [patent_doc_number] => 05792787 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'Treatment for atherosclerosis and other cardiovascular and inflammatory diseases' [patent_app_type] => 1 [patent_app_number] => 8/486239 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 16 [patent_no_of_words] => 8495 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792787.pdf [firstpage_image] =>[orig_patent_app_number] => 486239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3577820 [patent_doc_number] => 05498373 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-12 [patent_title] => 'Process for reducing the levels of nitrite contaminants in amine oxide surfactants' [patent_app_type] => 1 [patent_app_number] => 8/472793 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3906 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/498/05498373.pdf [firstpage_image] =>[orig_patent_app_number] => 472793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3766590 [patent_doc_number] => 05773231 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Treatment for atherosclerosis and other cardiovascular and inflammatory diseases' [patent_app_type] => 1 [patent_app_number] => 8/473272 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 37 [patent_no_of_words] => 17322 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773231.pdf [firstpage_image] =>[orig_patent_app_number] => 473272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3851843 [patent_doc_number] => 05767162 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists' [patent_app_type] => 1 [patent_app_number] => 8/470345 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19093 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 293 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767162.pdf [firstpage_image] =>[orig_patent_app_number] => 470345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3651165 [patent_doc_number] => 05684200 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-04 [patent_title] => 'Process for the preparation of hydroxylamine ethers and their salts and intermediates for this purpose' [patent_app_type] => 1 [patent_app_number] => 8/454371 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6124 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/684/05684200.pdf [firstpage_image] =>[orig_patent_app_number] => 454371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3838098 [patent_doc_number] => 05846959 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Treatment for atherosclerosis and other cardiovascular and inflammatory diseases' [patent_app_type] => 1 [patent_app_number] => 8/471537 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 37 [patent_no_of_words] => 17337 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846959.pdf [firstpage_image] =>[orig_patent_app_number] => 471537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3899565 [patent_doc_number] => 05750767 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Synthesis and use of amino acid fluorides as peptide coupling reagents' [patent_app_type] => 1 [patent_app_number] => 8/466319 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19798 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 241 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750767.pdf [firstpage_image] =>[orig_patent_app_number] => 466319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3699031 [patent_doc_number] => 05677343 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'Compound for inhibiting HIV infectivity' [patent_app_type] => 1 [patent_app_number] => 8/467725 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 34 [patent_no_of_words] => 17292 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/677/05677343.pdf [firstpage_image] =>[orig_patent_app_number] => 467725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4235859 [patent_doc_number] => 06075050 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'Compound for inhibiting HIV infectivity' [patent_app_type] => 1 [patent_app_number] => 8/467728 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 33 [patent_no_of_words] => 17325 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/075/06075050.pdf [firstpage_image] =>[orig_patent_app_number] => 467728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4305212 [patent_doc_number] => 06251948 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists' [patent_app_type] => 1 [patent_app_number] => 8/468028 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19021 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 300 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251948.pdf [firstpage_image] =>[orig_patent_app_number] => 468028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3775618 [patent_doc_number] => 05817664 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Uracil reductase inactivators' [patent_app_type] => 1 [patent_app_number] => 8/470317 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6332 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817664.pdf [firstpage_image] =>[orig_patent_app_number] => 470317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4371867 [patent_doc_number] => 06288123 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Therapeutic guanidines' [patent_app_type] => 1 [patent_app_number] => 8/464103 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43318 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 507 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288123.pdf [firstpage_image] =>[orig_patent_app_number] => 464103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4359470 [patent_doc_number] => 06174924 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-16 [patent_title] => 'Therapeutic guanidines' [patent_app_type] => 1 [patent_app_number] => 8/462013 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43670 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/174/06174924.pdf [firstpage_image] =>[orig_patent_app_number] => 462013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3584185 [patent_doc_number] => 05498793 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-12 [patent_title] => 'Catalytic process for the production of oximes' [patent_app_type] => 1 [patent_app_number] => 8/463554 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1386 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/498/05498793.pdf [firstpage_image] =>[orig_patent_app_number] => 463554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4199400 [patent_doc_number] => 06013675 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Therapeutic substituted guanidines' [patent_app_type] => 1 [patent_app_number] => 8/459974 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8445 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013675.pdf [firstpage_image] =>[orig_patent_app_number] => 459974 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3950676 [patent_doc_number] => 05955507 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Therapeutic substituted guanidines' [patent_app_type] => 1 [patent_app_number] => 8/459975 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8445 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955507.pdf [firstpage_image] =>[orig_patent_app_number] => 459975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4132799 [patent_doc_number] => 06147063 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Therapeutic substituted guanidines' [patent_app_type] => 1 [patent_app_number] => 8/458741 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26211 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/147/06147063.pdf [firstpage_image] =>[orig_patent_app_number] => 458741 [rel_patent_id] =>[rel_patent_doc_number] =>)